These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 22682548)

  • 1. [Graves' ophthalmopathy].
    Caballero Mora FJ; Martos Moreno GA; Gutiérrez Partida B; Argente J
    An Pediatr (Barc); 2012 Nov; 77(5):355-6. PubMed ID: 22682548
    [No Abstract]   [Full Text] [Related]  

  • 2. Management of Graves' ophthalmopathy.
    Wiersinga WM
    Nat Clin Pract Endocrinol Metab; 2007 May; 3(5):396-404. PubMed ID: 17452966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation and management of Graves' orbitopathy.
    Lee HB; Rodgers IR; Woog JJ
    Otolaryngol Clin North Am; 2006 Oct; 39(5):923-42, vi. PubMed ID: 16982255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical practice. Graves' ophthalmopathy.
    Bartalena L; Tanda ML
    N Engl J Med; 2009 Mar; 360(10):994-1001. PubMed ID: 19264688
    [No Abstract]   [Full Text] [Related]  

  • 5. [Combined idiopathic orbital inflammation and Graves' orbitopathy].
    Ciechanowski PP; Töteberg-Harms M; Pangalu A; Chaloupka K
    Klin Monbl Augenheilkd; 2012 Apr; 229(4):466-7. PubMed ID: 22496035
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapy-resistant thyroid diseases. 1.Graves' ophthalmopathy].
    Hiromatsu Y
    Nihon Naika Gakkai Zasshi; 2010 Apr; 99(4):755-62. PubMed ID: 20578362
    [No Abstract]   [Full Text] [Related]  

  • 7. [Graves' ophthalmopathy].
    Hiromatsu Y
    Nihon Rinsho; 2006 May; Suppl 1():307-10. PubMed ID: 16776151
    [No Abstract]   [Full Text] [Related]  

  • 8. Editorial. Graves' orbitopathy.
    von Arx GF
    Orbit; 2009; 28(4):209-13. PubMed ID: 19839876
    [No Abstract]   [Full Text] [Related]  

  • 9. Graves' disease: clinical pathophysiology, presentation and treatment options.
    Holt K
    J Pract Nurs; 2010; 60(3):13-8. PubMed ID: 21175104
    [No Abstract]   [Full Text] [Related]  

  • 10. [Management of Graves' orbitopathy. Comments on the EUGOGO consensus statement].
    Bednarczuk T; Bar-Andziak E; Hubalewska-Dydejczyk A; Waligórska A; Górska M; Myśliwiec J; Jarzab B; Karczmarzyk R; Zawadzka A; Garmol D; Kecik D; Królicki L; Plazińska MT; Krzeski A; Krzyzanowska-Swiniarska B; Lewiński A; Milewicz A; Daroszewski J; Placzkiewicz-Jankowska E; Pilarska K; Skórski M; Wiechno W; Sowiński J; Syrenicz A; Szafilk J; Wanyura H; Zgliczński W; Jastrzebska H; Nauman J
    Endokrynol Pol; 2009; 60(4):312-30. PubMed ID: 19753546
    [No Abstract]   [Full Text] [Related]  

  • 11. Management of patients with Graves' orbitopathy: initial assessment, management outside specialized centres and referral pathways.
    Orgiazzi J
    Clin Endocrinol (Oxf); 2016 May; 84(5):662-3. PubMed ID: 26866718
    [No Abstract]   [Full Text] [Related]  

  • 12. Age influences the severity of Graves' ophthalmopathy.
    Lin MC; Hsu FM; Bee YS; Ger LP
    Kaohsiung J Med Sci; 2008 Jun; 24(6):283-8. PubMed ID: 18635413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Graves' Orbitopathy].
    Eckstein A; Esser J; Mattheis S; Berchner-Pfannschmidt U
    Klin Monbl Augenheilkd; 2016 Dec; 233(12):1385-1407. PubMed ID: 27871109
    [No Abstract]   [Full Text] [Related]  

  • 14. Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on management of GO.
    Bartalena L; Baldeschi L; Dickinson A; Eckstein A; Kendall-Taylor P; Marcocci C; Mourits M; Perros P; Boboridis K; Boschi A; Currò N; Daumerie C; Kahaly GJ; Krassas GE; Lane CM; Lazarus JH; Marinò M; Nardi M; Neoh C; Orgiazzi J; Pearce S; Pinchera A; Pitz S; Salvi M; Sivelli P; Stahl M; von Arx G; Wiersinga WM;
    Eur J Endocrinol; 2008 Mar; 158(3):273-85. PubMed ID: 18299459
    [No Abstract]   [Full Text] [Related]  

  • 15. Management plan and delivery of care in Graves' ophthalmopathy patients.
    Yang M; Perros P
    Best Pract Res Clin Endocrinol Metab; 2012 Jun; 26(3):303-11. PubMed ID: 22632367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Graves' ophthalmopathy and dermopathy. Preface.
    Wiersinga WM
    Best Pract Res Clin Endocrinol Metab; 2012 Jun; 26(3):227. PubMed ID: 22632360
    [No Abstract]   [Full Text] [Related]  

  • 17. Optimal management of Graves orbitopathy: a multidisciplinary approach.
    Soeters MR; van Zeijl CJ; Boelen A; Kloos R; Saeed P; Vriesendorp TM; Mourits MP
    Neth J Med; 2011; 69(7):302-8. PubMed ID: 21934174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endoscopic orbital decompression for Graves' ophthalmopathy.
    Tang IP; Prepageran N; Shashinder S
    Med J Malaysia; 2008 Mar; 63(1):67-8. PubMed ID: 18935740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Graves' disease and Graves' ophthalmopathy with the polymorphisms in promoter and exon 1 of cytotoxic T lymphocyte associated antigen-4 gene.
    Zhang Q; Yang YM; Lv XY
    J Zhejiang Univ Sci B; 2006 Nov; 7(11):887-91. PubMed ID: 17048303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the National Eye Institute visual function questionnaire in Graves' ophthalmopathy.
    Bradley EA; Sloan JA; Novotny PJ; Garrity JA; Woog JJ; West SK
    Ophthalmology; 2006 Aug; 113(8):1450-4. PubMed ID: 16769116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.